background
pauciti
data
regard
differenti
characterist
patient
laboratoryconfirm
neg
middl
east
respiratori
syndrom
coronaviru
merscov
method
hospitalbas
casecontrol
studi
compar
merscovposit
patient
case
merscovneg
control
result
total
case
patient
control
mean
age
year
year
respect
p
includ
statist
differ
observ
relat
sex
presenc
fever
cough
presenc
singl
multilobar
infiltr
chest
radiographi
case
patient
like
overweight
control
group
mean
bodi
mass
index
vs
p
diabet
mellitu
vs
odd
ratio
p
endstag
renal
diseas
vs
p
time
admiss
tachypnea
vs
p
respiratori
distress
vs
p
less
frequent
among
case
patient
merscov
patient
like
normal
white
blood
cell
count
control
group
vs
p
admiss
chest
radiographi
interstiti
infiltr
frequent
case
patient
control
vs
p
case
patient
like
admit
intens
care
unit
vs
p
high
mortal
rate
vs
p
conclus
clinic
predictor
could
enhanc
abil
predict
patient
pneumonia
would
merscov
howev
prospect
analysi
match
casecontrol
studi
may
shed
light
predictor
infect
arabia
septemb
first
describ
case
result
acut
pneumonia
subsequ
renal
failur
death
similar
clinic
present
sar
retrospect
test
first
hospit
outbreak
merscov
infect
link
hospit
zarqa
jordan
merscov
caus
sporad
infect
intrafamili
healthcareassoci
infect
sinc
first
case
identifi
total
case
fatal
rate
report
saudi
arabia
asymptomat
mildli
symptomat
case
document
among
famili
healthcar
worker
contact
confirm
case
patienttopati
transmiss
intrafamili
transmiss
also
report
march
total
case
worldwid
report
world
health
organ
initi
case
appear
sporad
natur
epidemiolog
link
middl
east
april
may
total
case
merscov
infect
report
hospit
outbreak
eastern
provinc
saudi
arabia
clinic
present
characterist
merscov
patient
well
describ
merscov
still
fairli
new
diseas
pauciti
data
regard
characterist
differ
suspect
patient
whose
test
subsequ
neg
laboratoryconfirm
case
studi
would
use
triag
patient
risk
categori
determin
likelihood
merscov
infect
undertook
studi
identifi
possibl
clinic
characterist
may
differenti
merscovposit
patient
merscovneg
patient
communityacquir
pneumonia
cap
casecontrol
studi
case
defin
hospit
patient
test
posit
merscov
april
june
control
select
pool
patient
admit
facil
timefram
met
case
definit
suspect
merscov
test
neg
merscov
case
definit
suspect
merscov
acut
febril
respiratori
ill
fever
cough
dyspnea
radiograph
evid
pneumonia
studi
conduct
gener
hospit
also
accept
refer
patient
hospit
provid
medic
care
individu
elig
medic
care
hospit
intens
care
unit
cardiac
medic
surgic
pediatr
neonat
patient
suspect
merscov
infect
either
dacronflock
nasopharyng
swab
tracheal
aspir
specimen
submit
saudi
ministri
health
merscov
laboratori
clinic
sampl
screen
realtim
reversetranscript
polymeras
chain
reaction
describ
previous
test
amplifi
upstream
e
protein
upe
gene
merscov
posit
case
determin
assay
posit
control
classifi
merscov
test
neg
describ
previous
collect
data
patient
use
standard
microsoft
excel
spreadsheet
paper
chart
electron
medic
record
review
conduct
practic
physician
second
review
chart
done
differ
investig
ensur
concord
abstract
data
interrat
agreement
high
variabl
investig
blind
merscov
statu
posit
neg
collect
epidemiolog
demograph
clinic
radiograph
laboratori
data
radiograph
featur
chest
radiograph
extract
radiograph
report
base
search
keyword
lobar
unilater
interstiti
infiltr
statist
analysi
done
use
spss
softwar
window
version
spss
chicago
illinoi
descript
analys
done
demograph
clinic
laboratori
data
bivari
analysi
associ
merscov
statu
differ
paramet
done
continu
data
complet
blood
count
lactat
dehydrogenas
ldh
hepat
panel
platelet
count
convert
categor
variabl
normal
low
high
level
multivari
analysi
perform
due
small
sampl
size
odd
ratio
obtain
variabl
well
p
valu
consid
indic
statist
signific
kaplanmei
surviv
curv
calcul
merscovposit
case
vs
control
date
onset
symptom
use
start
date
endpoint
either
death
surviv
novemb
conduct
death
certif
search
medic
record
determin
patient
aliv
discharg
subsequ
die
data
includ
analysi
applic
studi
period
total
patient
admit
met
case
definit
suspect
merscov
case
control
mean
age
year
case
year
control
p
statist
differ
exist
case
control
look
sex
age
presenc
fever
cough
admiss
whether
patient
singl
multilobar
infiltr
chest
radiographi
tabl
merscov
case
like
overweight
control
mean
bodi
mass
index
kgm
vs
kgm
p
tabl
result
bivari
analysi
reveal
differ
mani
underli
comorbid
case
control
tabl
signific
comorbid
diabet
mellitu
endstag
renal
diseas
esrd
case
esrd
requir
chronic
hemodialysi
compar
control
vs
p
presenc
cardiac
diseas
pulmonari
diseas
activ
cancer
statist
differ
group
tabl
median
time
symptom
onset
hospit
day
case
control
median
durat
hospit
either
discharg
death
day
case
day
control
time
admiss
tachypnea
vs
p
respiratori
distress
vs
p
less
frequent
seen
among
case
control
tabl
presenc
fever
short
breath
wheez
chest
pain
cough
hemoptysi
sore
throat
headach
myalgia
vomit
diarrhea
statist
differ
group
comparison
mean
laboratori
data
case
control
shown
tabl
admiss
patient
merscov
like
normal
white
blood
cell
count
wbc
control
vs
p
case
less
like
leukocytosi
control
vs
p
tabl
level
lymphocytosi
differ
statist
group
admiss
chest
radiographi
show
presenc
interstiti
infiltr
frequent
case
control
vs
p
illustr
radiograph
show
interstiti
infiltr
merscovposit
patient
shown
figur
blood
sputum
cultur
reveal
specif
etiolog
cap
merscovneg
patient
mortal
rate
among
case
compar
among
control
p
kaplanmei
surviv
curv
rightcensor
patient
aliv
end
studi
period
shown
figur
day
case
aliv
compar
control
studi
identifi
total
patient
test
posit
merscov
look
potenti
risk
factor
predictor
diseas
identifi
addit
patient
met
case
definit
suspect
merscov
ultim
test
neg
diseas
group
similar
age
sex
median
age
year
case
previous
report
median
age
case
year
male
predomin
patient
case
vs
control
group
reach
statist
signific
earlier
studi
show
male
predomin
current
studi
recent
analysi
show
larger
proport
younger
femal
case
reduct
maletofemal
ratio
one
reason
chang
epidemiolog
diseas
enhanc
surveil
detect
mildli
symptomat
case
clinic
present
merscov
infect
initi
describ
sever
lead
pneumonia
acut
respiratori
distress
syndrom
ard
septic
shock
multiorgan
failur
result
death
subsequ
patient
mild
symptom
report
initi
present
diseas
differ
caus
cap
patient
may
sore
throat
chill
arthralgia
myalgia
current
studi
symptom
present
merscovposit
merscovneg
patient
equal
rate
thu
symptom
poor
discrimin
power
merscov
infect
time
admiss
tachypnea
respiratori
distress
less
frequent
seen
among
case
control
vs
vs
respect
tabl
exact
reason
differ
known
find
confirm
subsequ
studi
would
import
distinguish
characterist
underli
comorbid
esrd
identifi
risk
factor
merscov
infect
diarrhea
vomit
observ
patient
current
studi
presenc
diarrhea
vomit
present
case
control
observ
rate
gastrointestin
symptom
lower
previou
studi
may
relat
small
number
includ
patient
presenc
vomit
diarrhea
merscov
patient
signific
impact
infect
control
measur
admiss
patient
merscov
like
normal
wbc
vs
control
group
less
like
leukocytosi
case
vs
thu
normal
wbc
count
admiss
patient
cap
may
help
predict
merscov
posit
suggest
mani
control
may
bacteri
pneumonia
howev
blood
sputum
cultur
reveal
specif
etiolog
cap
patient
previous
lymphopenia
observ
among
merscov
patient
found
differ
presenc
lymphopenia
among
case
control
elev
ldh
aspart
aminotransferas
ast
alanin
aminotransferas
alt
observ
merscov
patient
respect
consist
observ
also
found
merscov
patient
elev
ldh
ast
alt
find
specif
merscov
patient
observ
similarli
control
admiss
chest
radiographi
show
presenc
interstiti
infiltr
frequent
case
control
previou
radiograph
characterist
includ
bilater
infiltr
unilater
infiltr
initi
chest
radiographi
patient
zarqa
jordan
hospit
outbreak
show
singlelobar
bilater
multilobar
pneumonia
ct
scan
characterist
ard
includ
interstiti
infiltr
seen
sever
case
presenc
interstiti
infiltr
compat
sever
present
case
may
marker
cardiac
diseas
cardiomegali
identifi
potenti
risk
factor
bivari
analysi
studi
mortal
rate
merscov
patient
significantli
higher
control
group
find
consist
earli
find
higher
mortal
among
merscov
patient
subsequ
analysi
initi
case
reveal
case
fatal
rate
earli
period
diseas
apriljun
higher
fatal
rate
second
period
diseas
anoth
analysi
hospit
patient
die
differ
relat
identif
mild
case
asymptomat
case
mortal
rate
merscov
infect
also
relat
number
underli
risk
factor
underli
condit
compar
underli
condit
patient
link
epidemiolog
previous
describ
alhasa
outbreak
fact
might
explain
higher
proport
case
underli
medic
condit
merscov
infect
may
result
mild
sever
fulmin
infect
lead
ard
requir
hospit
current
studi
median
time
symptom
onset
hospit
day
case
control
hand
median
durat
hospit
discharg
death
day
case
day
control
previou
analysi
median
time
symptom
onset
hospit
day
median
time
admiss
intens
care
unit
death
day
respect
one
patient
treat
extracorpor
membran
oxygen
die
day
symptom
onset
proven
effect
therapi
merscov
infect
avail
therapi
base
analysi
treatment
patient
sever
acut
respiratori
syndrom
recent
use
interferon
ribavirin
combin
merscov
result
improv
outcom
mani
patient
present
late
ill
sever
limit
studi
first
small
number
case
limit
abil
detect
discrimin
factor
present
second
retrospect
natur
studi
may
also
limit
power
studi
identifi
clinic
predictor
third
inclus
patient
alhasa
outbreak
may
contribut
absenc
signific
predictor
merscov
may
explain
high
proport
esrd
diabet
patient
among
case
one
strength
studi
ascertain
case
control
master
list
includ
case
admit
rule
merscov
infect
studi
period
conclus
result
suggest
clinic
predictor
could
enhanc
abil
predict
patient
cap
would
merscov
howev
prospect
analysi
match
casecontrol
studi
may
shed
light
possibl
predictor
infect
